Swalqol in Primary Hyperparathyroidism

Uşak University

Status: Completed

Conditions: Hyperparathyroidism

Treatments: Procedure: parathyroidectomy

Study type: Observational

Funder types: Other

Identifiers

NCT03968510

pthswalqol

Details and patient eligibility

About

Swallow related quality of life before and after parathyroidectomy will be evaluated in patients with primary hyperparathyridism.

Full description

Patients who will undergone parathyroidectomy for primary hyperparathyroidism will be included in the study. Swal-Qol and Sf-36 forms will be used for evaluation of quality of life before and 1 month after the surgery. The change in the quality of life and swallowing related quality of life will be evaluated.

Enrollment: 150 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• no diagnosis of Alzheimers disease
• must be able to swallow tablets Planned operation for primary hyperparathyroidism

Exclusion criteria

• secondary or tertiary hyperparathyroidism
• insulin dependent diabetes
• thyroid disease

Trial design

150 participants in 1 patient group

parathyroidectomy cases

Description:

patients who will be operated for primary hyperparathyroidism

Treatment:

Procedure: parathyroidectomy